Inflammation, metaflammation and immunometabolic disorders
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertrophic visceral adipose tissue is a primary driver of chronic, low-grade meta-inflammation, characterized by an accelerated secretion of pro-inflammatory cytokines (such as TNF-alpha and IL-6) and a concomitant reduction in protective adiponectin [9,11,12].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Excess visceral adiposity does not merely represent a passive energy reserve; rather, it acts as an active immunometabolic organ [8-10].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Inflammageing is now being recognized as a hallmark of ageing and a key driver of disease (FIG. 3Aa), including ageing-associated diseases, and has been described as a prominent risk factor for morbidity and death95–97.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“Chronic inflammation has profound effects on systemic metabolism, via a complicated crosstalk between immune cells and metabolic cells, such as hepatocytes and adipocytes, influencing metabolic processes such as glucose and lipid uptake, and insulin sensitivity96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“For example, in obese tissues such as the visceral fat, peripheral monocytes are recruited by stressed adipocytes, leading to a progressive infiltration of proinflammatory M1-like macrophages and the displacement of the resident, anti-inflammatory M2 macrophages96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Collino, M., Benetti, E., Rogazzo, M., Chiazza, F., Mastrocola, R., Nigro, D., Cutrìn, J. C., Aragno, M., Fantozzi, R., Minetto, M. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12888 · Cited by 25
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Cited by
Items 501–600 of 1,004
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.715981 · Cited by 49
“Life expectancy of T2DM patients has been reported to be about 6 years shorter than that of age-matched healthy controls, mainly due to the increased risk for progressive disability due to T2DM-associated chronic diseases and increased age (Huang et al., 2014).”
BackgroundLeung, H., Xiong, L., Ni, Y., Busch, A., Bauer, M. W., Press, A. T., & Panagiotou, G. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00398-0 · Cited by 49
The Effect of Sleep Disruption on Cardiometabolic Health
Hong, S., Lee, D.-B., Yoon, D. W., Yoo, S.-L., & Kim, J. (2025) · Life · doi:10.3390/life15010060 · Cited by 64
Al‐Rashed, F., Ahmad, Z., Iskandar, M. M. A., Tuomilehto, J. O., Al‐Mulla, F., & Ahmad, R. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000028 · Cited by 45
The Role of Mitochondria in Immune-Cell-Mediated Tissue Regeneration and Ageing
Su, Y., Wang, P., & Weng, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052668 · Cited by 49
“Among the meta-flammation disorders, abdominal obesity and diabetes are among the main pathologies associated with the increased burden of cellular senescence [56], and are clustered with a group of risk factors related to cardiovascular diseases [57].”
BackgroundLi, C., Ma, Q., Gao, X., Wang, X., & Zhang, B.-L. (2021) · Marine Drugs · doi:10.3390/md19100572 · Cited by 47
Joseph, A., Moriceau, S., Sica, V., Anagnostopoulos, G., Pol, J., Martins, I., Lafarge, A., Maiuri, M. C., Leboyer, M., Loftus, J., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2716-5 · Cited by 44
“Intriguingly, obesity is coupled to a state of chronic in fl ammation in which TNF α is elevated, contributing to the development of insulin-resistant (type-2) diabetes 5,6 .”
Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota
Bishehsari, F., Engen, P. A., Adnan, D., Sarrafi, S., Wilber, S., Shaikh, M. W., Green, S. J., Naqib, A. D., Giron, L. B., Abdel‐Mohsen, M., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.11.007 · Cited by 55
Liu, Y., Zheng, S., Cui, J., Guo, T., & Zhang, J. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00686-5 · Cited by 48
“T2D is considered as a state of chronic low-grade inflammation [34].”
BackgroundTransition Metal‐Based Therapies for Inflammatory Diseases
Song, Y., You, Q., & Chen, X. S. (2023) · Advanced Materials · doi:10.1002/adma.202212102 · Cited by 50
NIRANJAN, S., Phillips, B. E., & Giannoukakis, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193373 · Cited by 51
MiR-145 improves macrophage-mediated inflammation through targeting Arf6
Li, R., Shen, Q., Wu, N., He, M., Liu, N., Huang, J., Lü, B., Yao, Q., Yang, Y., & Hu, R. (2018) · Endocrine · doi:10.1007/s12020-018-1521-8 · Cited by 45
“JNK, p-38, and subsequent secretion of pro-inflammatory cytokines [7].”
BackgroundAbnormal brown adipose tissue mitochondrial structure and function in IL10 deficiency
Júnior, J. C. D. L., de Souza, G. F. P., Moura‐Assis, A., Gaspar, R. S., Gaspar, J. M., Rocha, A. L. S., Ferrucci, D. L., de Lima, T. I., Victorio, S. C. D. S., Bonfante, I. L. P., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.041 · Cited by 50
“Systemic low-grade inflammation is a hallmark of obesity and is regarded as the most important mechanism linking obesity and insulin resistance [28,68].”
BackgroundMicroglia immunometabolism: From metabolic disorders to single cell metabolism
Paolicelli, R. C., & Angiari, S. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.03.012 · Cited by 45
Viral Infections and Interferons in the Development of Obesity
Tian, Y., Jennings, J., Gong, Y., & Sang, Y. (2019) · Biomolecules · doi:10.3390/biom9110726 · Cited by 48
“In turn, through over-production of long-chain fatty acid (LFA) and leptin by expanding adipocytes, obesity is accompanied with general immune suppression including aberration of antiviral IFN signaling, which leads to high susceptibility to viral infections (Figure 3) [4,11,48,107,109].”
BackgroundInfluentialIL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders
Luotola, K. (2022) · Nutrients · doi:10.3390/nu14163422 · Cited by 53
“IL-1β plays an important role in metabolic disease and the development of diabetes that were supported in studies with a deficiency of mature cytokine or signaling leading to insulin resistance and the inhibition of IL-1β-mediated action that was shown to improve pancreatic beta-cell function [1].”
BackgroundModulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
Spano, M., Matteo, G. D., Ingallina, C., Ambroselli, D., Carradori, S., Gallorini, M., Giusti, A. M., Salvo, A., Grosso, M., & Mannina, L. (2022) · Nutrients · doi:10.3390/nu14030490 · Cited by 45
The obesity–inflammation axis in psoriatic disease: mechanisms and therapeutic strategies
Haberman, R. H., Ogdie, A., Merola, J. F., Scher, J. U., & Eder, L. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01326-6 · Cited by 50
“…that results from metabolically active organs such as adipose tissue, the liver, brain and pancreas) which is termed ‘metaflammation’ 78,79 and is associated with obesity, creates a systemic, low-grade pro-inflammatory milieu that might lower the threshold for PsA development in…”
Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver
Guaraldi, G., Lonardo, A., Maia, L. E. O., & Palella, F. J. (2017) · AIDS · doi:10.1097/qad.0000000000001483 · Cited by 47
Inflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects
Catalán, V., Frühbeck, G., & Gómez‐Ambrosi, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00008-8 · Cited by 66
Zhou, J., Yao, N., Wang, S., An, D., Cao, K., Wei, J., Li, N., Zhao, D., Wang, L., Chen, X., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.01.041 · Cited by 47
Evaluation of the etiology of persistent iritis after cataract surgery
Neatrour, K., McAlpine, A., Owens, T. B., Trivedi, R. H., & Perry, L. J. P. (2019) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-019-0170-2 · Cited by 43
Lin, H., Weng, S., Shen, F., Chang, Y., Lian, W., Hsieh, C., Chuang, J., Lin, T., Liou, C., Chang, C., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7737 · Cited by 45
Exercise and Adipose Tissue Immunity: Outrunning Inflammation
Winn, N. C., Cottam, M. A., Wasserman, D. H., & Hasty, A. H. (2021) · Obesity · doi:10.1002/oby.23147 · Cited by 53
“mation is triggered or heightened in large part by (1) accelerated”
BackgroundInfluentialIbrahim, S. R. M., Sirwi, A., Eid, B. G., Mohamed, S. G. A., & Mohamed, G. A. (2021) · Metabolites · doi:10.3390/metabo11100683 · Cited by 43
Zhen, D., Xuan, T.-Q., Hu, B., Bai, X., Fu, D., Wang, Y., Wu, Y., Yang, J., & Ma, Q. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114753 · Cited by 43
Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?
Tate, A. R., & Rao, G. H. R. (2024) · Biomolecules · doi:10.3390/biom14080948 · Cited by 42
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 51
Gastaldi, S., Rocca, C., Gianquinto, E., Granieri, M. C., Boscaro, V., Blua, F., Rolando, B., Marini, E., Gallicchio, M., Bartolo, A. D., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115542 · Cited by 46
“…confined to adipose tissue, but the obesity-related influx of immune cells occurs in many other tissues that produce inflammatory mediators (e.g., cytokines and chemotactic molecules) that influence immune cells ’ action and compromise the physiology of several organs including the heart [14,57].”
Frühbeck, G., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Valentí, V., Moncada, R., Becerril, S., Unamuno, X., Silva, C., Salvador, J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.04.004 · Cited by 45
The Impact of Obesity and Metabolic Surgery on Chronic Inflammation
Chiappetta, S., Schaack, H. M., Wölnerhannsen, B., Stier, C. K., Squillante, S., & Weiner, R. A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3320-y · Cited by 46
de Souza, M. Q., Teotônio, I. M. S. N., de Almeida, F. C., Cardoso, G. S. H. R., Alves, P. S., Romeiro, L. A. S., Pratesi, R., Nóbrega, Y. K. D. M., & Pratesi, C. B. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2247-0 · Cited by 52
“The rapid release of pro-inflammatory cytokines by activated macrophages plays a crucial role in triggering local immune response [21].”
BackgroundObesity Accelerates Age Defects in Mouse and Human B Cells
Frasca, D., & Blomberg, B. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02060 · Cited by 44
“IR also increases with age (22, 23), and is associated with high serum levels of glucose and free fatty acids (FFAs), and markers of metabolic inflammation, metaflammation (24), that fuels inflammaging and promotes aging, diseases and death.”
BackgroundLiu, C., Yuan, Y., Zhou, J., Hu, R., Ji, L., & Jiang, G. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00617-1 · Cited by 52
Brennan, F. H., Noble, B. T., Wang, Y., Guan, Z., Davis, H., Mo, X. M., Harris, J. C., Eroğlu, Ç., Ferguson, A. R., & Popovich, P. G. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108667 · Cited by 47
“Indeed, immune and metabolic processes are inextricably linked, and the α2δ−1 subunit is expressed on various cell types in immune and metabolic organs (Gee et al., 1996; Gong et al., 2001; Hotamisligil, 2017).”
BackgroundZhang, M., Zhu, S., Ho, C., & Huang, Q. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.046 · Cited by 43
Cyclodextrins as Anti-inflammatory Agents: Basis, Drugs and Perspectives
Appleton, S. L., Navarro‐Orcajada, S., Martínez-Navarro, F. J., Caldera, F., López-Nicolás, M., Trotta, F., & Matencio, A. (2021) · Biomolecules · doi:10.3390/biom11091384 · Cited by 49
Immunometabolism: Where Immunology and Metabolism Meet
Chavakis, T. (2021) · Journal of Innate Immunity · doi:10.1159/000521305 · Cited by 49
Varnousfaderani, S. D., Musazadeh, V., Ghalichi, F., Kavyani, Z., Razmjouei, S., Faghfouri, A. H., Ahrabi, S. S., Shoura, S. M. S., & Dehghan, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1191290 · Cited by 44
Roles of immune dysregulation in MASLD
Dong, T., Li, J., Liu, Y., Zhou, S., Wei, X., Hua, H., Tang, K., Zhang, X., Wang, Y., Wu, Z. F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116069 · Cited by 50
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 45
“Advanced liver fibrosis leads to cirrhosis, liver failure [6, 7].”
BackgroundLucht, S. A., Hennig, F., Moebus, S., Ohlwein, S., Herder, C., Kowall, B., Jöckel, K., & Hoffmann, B. H. (2020) · Environment International · doi:10.1016/j.envint.2020.105493 · Cited by 46
Zhou, Z., Tao, Y., Zhao, H., & Wang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666344 · Cited by 44
“Kinds of soluble factors, comprising adipokines, cytokines, growth factors and fatty acids, are involved in the intercellular communication to regulate immunity and metabolism, which have been well reviewed elsewhere and will not be detailed here (1, 5, 8, 11, 12).”
BackgroundSergi, D., Luscombe‐Marsh, N. D., Naumovski, N., Abeywardena, M. Y., & O’Callaghan, N. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.663838 · Cited by 46
“Metabolic inflammation, defined as a sterile inflammatory response (51) and typical of obesity and the metabolic syndrome (52), has been widely described for its ability to induce insulin resistance in metabolically active tissues (6, 51, 53, 54).”
BackgroundRegression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review
Khan, S., & Saxena, R. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000312 · Cited by 46
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b
Patel, S. J., Liu, N., Piaker, S., Gulko, A., Andrade, M. L., Heyward, F. D., Sermersheim, T. J., Edinger, N., Srinivasan, H., Emont, M. P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abh3831 · Cited by 42
Maric, T., Bazhin, A. A., Khodakivskyi, P. V., Mikhaylov, G., Solodnikova, E. S., Yevtodiyenko, A., Attianese, G. M. P. G., Coukos, G., Irving, M. B., Joffraud, M., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114826 · Cited by 45
Gu, Y., Hu, K., Huang, Y., Zhang, Q., Liu, L., Ge, M., Wu, H., Xia, Y., Bao, X., Shi, H., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.041 · Cited by 48
Naghsh, N., Musazadeh, V., Nikpayam, O., Kavyani, Z., Moridpour, A. H., Golandam, F., Faghfouri, A. H., & Ostadrahimi, A. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/4875636 · Cited by 44
Xiang, X., Xu, M., Liu, L., Meng, N., Yu, L., Feng, Y., & Tang, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-60159-7 · Cited by 40
“Additionally, obesity, characterized by chronic inflammation and cellular stress, has been associated with ERS 51,52 .”
Roles for Siglec-glycan interactions in regulating immune cells
Lin, S.-Y., Schmidt, E. N., Takahashi, K., & Macauley, M. S. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101925 · Cited by 45
Kors, L., Rampanelli, E., Stokman, G., Butter, L. M., Held, N. M., Claessen, N., Larsen, P. W. B., Verheij, J., Zuurbier, C. J., Liebisch, G., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.003 · Cited by 51
Integrative Analysis Revealing Human Adipose-Specific Genes and Consolidating Obesity Loci
Ahn, J., Wu, H., & Lee, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39582-8 · Cited by 44
Dong, G., Qu, L., Gong, X., Pang, B., Yan, W., & Wei, J. (2019) · International Journal of Endocrinology · doi:10.1155/2019/8749291 · Cited by 49
“Systemic lowgrade inflammatory response and a large number of inflammatorymediators are knownpathological features of diabetes [7].”
BackgroundKim, Y., Sundrud, M. S., Zhou, C., Edenius, M., Zocco, D., Powers, K., Zhang, M., Mazitschek, R., Rao, A., Yeo, C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913788117 · Cited by 43
Bertocchi, I., Foglietta, F., Collotta, D., Eva, C. E., Brancaleone, V., Thiemermann, C., & Collino, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15229 · Cited by 40
“…impaired metabolism and immunity in obeserelated metabolic derangements is well documented, and the term “metaflammation” has been coined to indicate a pathophysiological inflammatory response resulting from metabolic alterations and dysfunctions (Hotamisligil, 2017; Mastrocola et al., 2018).”
BackgroundThe intrinsic and extrinsic elements regulating inflammation
Mollaei, M., Abbasi, A., Hassan, Z. M., & Pakravan, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118258 · Cited by 44
Wu, Y., Xue-ya, L., Tan, F., Zhou, X., Mu, J., & Zhao, X. (2021) · Journal of Inflammation · doi:10.1186/s12950-021-00272-w · Cited by 47
Macrophages at the Crossroad of Meta-Inflammation and Inflammaging
Qu, L., Matz, A., Karlinsey, K. S., Cao, Z., Vella, A. T., & Zhou, B. (2022) · Genes · doi:10.3390/genes13112074 · Cited by 44
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
Zhao, Z., Wang, D., & Li, Y. (2023) · Medical Review · doi:10.1515/mr-2022-0046 · Cited by 41
“Additionally, inflammation is a protective response to injury or infection, which proved to be associated with many human diseases and even cancers [6, 7].”
BackgroundPerakakis, N., Harb, H., Hale, B. G., Varga, Z., Steenblock, C., Kanczkowski, W., Alexaki, V. I., Ludwig, B., Mirtschink, P., Solimena, M., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00154-7 · Cited by 50
Zhen, J., Gu, Y., Wang, P., Wang, W., Bian, S., Huang, S., Liang, H., Huang, M., Yu, Y., Chen, Q., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06065-5 · Cited by 39
“Second, the genetic determinants of FPG (examined in the first trimester) and OGTT0H (examined between 24 and 28 gestational weeks) were highly similar, sharing seven significant genetic loci (Fig.”
Ji, W., Li, H., Qi, Y., Zhou, W., Chang, Y., Xu, D., & Yuxi, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-77802-y · Cited by 40
“The observed association between NPAR and MetS aligns with the growing body of evidence implicating chronic low-grade inflammation in the pathogenesis of metabolic disorders 4,18 .”
BackgroundMetaflammation’s Role in Systemic Dysfunction in Obesity: A Comprehensive Review
Crasan, I.-M., Tanase, M., Delia, C., Pîrcălăbioru, G. G., Cîmpean, A., & Ionica, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110445 · Cited by 46
Ritter, A., Louwen, F., & Yuan, J. (2018) · Obesity Reviews · doi:10.1111/obr.12716 · Cited by 40
“Obesity is featured by systemic low-grade chronic inflammation and metabolic dysfunction in the central hypothalamus and in periphery organs like the liver, the pancreas and adipose tissue (3,119,120).”
BackgroundGiannattasio, S., Corinaldesi, C., Colletti, M., Luigi, L. D., Antinozzi, C., Filardi, T., Scolletta, S., Basili, S., Lenzi, A., Morano, S., et al. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0977-y · Cited by 39
Nutrient Sensing in CD11c Cells Alters the Gut Microbiota to Regulate Food Intake and Body Mass
Chagwedera, D. N., Ang, Q. Y., Bisanz, J. E., Leong, Y. A., Ganeshan, K., Cai, J., Patterson, A. D., Turnbaugh, P. J., & Chawla, A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.002 · Cited by 40
“Previous studies have highlighted a role for inflammation and microbial dysbiosis in metabolic dysfunction associated with disease states of obesity and insulin resistance (Hotamisligil, 2017; Lee et al., 2018; Maruvada et al., 2017; Schroeder and Backhed, 2016; Sonnenburg and Backhed, 2016).”
BackgroundInfluentialImmune Cells Gate White Adipose Tissue Expansion.
Cox, A., Chernis, N., Masschelin, P. M., & Hartig, S. (2019) · Endocrinology · doi:10.1210/en.2019-00266 · Cited by 36
Yang, H., Graham, L. C., Reagan, A. M., Grabowska, W. A., Schott, W. H., & Howell, G. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1527-z · Cited by 39
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Ferreira, V., Grajales, D., & Valverde, Á. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158534 · Cited by 45
POMC Neurons Dysfunction in Diet-induced Metabolic Disease: Hallmark or Mechanism of Disease?
Quarta, C., Fioramonti, X., & Cota, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.031 · Cited by 43
Luo, Y., Wang, X., & Cao, Y. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109325 · Cited by 39
Kowalska, K., Dembczyński, R., Gołąbek-Grenda, A., Olkowicz, M., & Olejnik, A. M. (2021) · Nutrients · doi:10.3390/nu13030885 · Cited by 43
“Fatty acid-binding protein 4 (FABP4), also named adipocyte FABP or aP2, is mostly expressed in fat cells and plays significant roles in developing insulin resistance and atherosclerosis concerning metabolically driven low-grade and chronic inflammation [26].”
BackgroundAnti-Inflammatory Activity and Mechanism of Cryptochlorogenic Acid from Ageratina adenophora
Ma, X., Okyere, S. K., Hu, L., Wen, J., Ren, Z., Deng, J., & Hu, Y. (2022) · Nutrients · doi:10.3390/nu14030439 · Cited by 39
Lipid metabolism in tumor microenvironment: novel therapeutic targets
Liu, X., Zhang, P., Xu, J., Lv, G., & Li, Y. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02645-4 · Cited by 41
Cai, H., Wen, Z., Zhao, L., Yu, D., Meng, K., & Yang, P. (2022) · Food & Nutrition Research · doi:10.29219/fnr.v66.7974 · Cited by 43
“Obesity is a common chronic metabolic disease in many developed and developing countries that raise the risk for type 2 diabetes, cardiovascular disease, and hepatic steatosis (1).”
BackgroundMalate initiates a proton-sensing pathway essential for pH regulation of inflammation
Chen, Y., Shi, R.-C., Xiang, Y.-C., Li, F., Tang, H., He, G., Zhou, M. L., Feng, X.-Z., Tan, J.-D., Huang, P., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02076-9 · Cited by 42
CoQ imbalance drives reverse electron transport to disrupt liver metabolism
Goncalves, R. L. S., Wang, Z. B., Riveros, J. K., Parlakgül, G., Inouye, K., Lee, G. Y., Fu, X., Saksi, J., Rosique, C., Hui, S. T., et al. (2025) · Nature · doi:10.1038/s41586-025-09072-1 · Cited by 48
Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?
Grunhut, J., Wang, W., Aykut, B., Gakhal, I., Torres-Hernandez, A., & Miller, G. (2018) · EMJ Hepatology · doi:10.33590/emjhepatol/10312252 · Cited by 38
Reversal of prolonged obesity-associated cerebrovascular dysfunction by inhibiting microglial Tak1
Shen, Q. X., Chen, Z., Zhao, F., Pan, S., Zhang, T., Cheng, X., Zhang, L., Zhang, S., Qi, J., Li, J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0642-6 · Cited by 40
Gonçalves, R. M., Delgobo, M., Agnes, J. P., das Neves, R. N., Falchetti, M., Casagrande, T. S., Garcia, A. P. V., Vieira, T. C., Somensi, N., Bruxel, M. A., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.003 · Cited by 44
Ketogenic Diets and Cardio-Metabolic Diseases
Zhang, W., Guo, X., Chen, L., Chen, T., Yu, J., Wu, C., & Zheng, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.753039 · Cited by 46
“The occurrence and development of CMDs are closely related to systemic chronic low-grade inflammation characterized by the continuous increase of circulatory inflammatory factors (42).”
BackgroundResilience integrates concepts in aging research
Promislow, D., Anderson, R. M., Scheffer, M., Crespi, B. J., DeGregori, J. V., Harris, K., Natterson-Horowitz, B., Levine, M. E., Riolo, M. A., Schneider, D. S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104199 · Cited by 46
“Importantly, the very repair systems that help recovery from perturbations, such as immunity, inflammation, and autophagy, also lose resilience (Hotamisligil, 2017; Labbadia and Morimoto, 2015).”
BackgroundMiRNA-132/212 encapsulated by adipose tissue-derived exosomes worsen atherosclerosis progression
Guo, B., Zhuang, T., Li, C., Li, F., Shan, S., Zheng, M.-H., Xu, Q.-S., Wang, Y., Lei, L.-M., Tang, K.-X., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02404-x · Cited by 41
Understanding vertebrate immunity through comparative immunology
Boehm, T. L. J. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01083-9 · Cited by 43
“Considering the immuno-suppressive function of butyrophylins 189 , it is possible that this is one mechanism to reduce the extent of chronic inflammation, which is known to be strongly associated with organismal ageing 190 .”
Oxidative Stress and Inflammation in Obesity and Metabolic Syndrome
Ruiz‐Ojeda, F. J., Olza, J., Gil, Á., & Aguilera, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00001-5 · Cited by 56
Wang, A., Dongcheng, C., Zhang, H., Li, Q., Yan, Z., Qiu, Y., Xu, H., & Keji, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.018 · Cited by 40
Perivascular adipose tissue in cardiovascular diseases – an update
Grigoraş, A. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.91380 · Cited by 38
“This type of inflammatory reaction is not induced by an antigen, but it is rather orchestrated by metabolic cells in response to excess nutrients and energy (41).”
BackgroundMazidi, M., Kengne, A. P., George, E. S., & Siervo, M. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519002149 · Cited by 41
“Hence, we hypothesised that a high energy diet which contains excess red meat and is high in SFA may be associated with weight gain and thus increased adiposity and subsequently contribute to developing unfavourable glucose/insulin homoeostasis enhancing low-grade inflammation, which is strongly linked to the pathogen…”
Wen, Q., Miao, J., Lau, N., Zhang, C., Peng, Y., Du, S., Mei, L., Weng, H., Xu, Q., Liu, X., et al. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0389 · Cited by 39
Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?
Lugnier, C., Meyer, A., Talha, S., & Gény, B. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107475 · Cited by 39
Alliin, An Allium sativum Nutraceutical, Reduces Metaflammation Markers in DIO Mice
Sánchez-Sánchez, M. A., Zepeda‐Morales, A. S. M., Carrera-Quintanar, L., Paredes, J. M. V., Franco‐Arroyo, N. N., Godínez-Rubí, M., Ortuño‐Sahagún, D., & López-Roa, R. I. (2020) · Nutrients · doi:10.3390/nu12030624 · Cited by 44
“In those models, however, the inflammatory process is generated by an acute and strong LPS insult, while obesity is characterized by a low-grade inflammatory state, hence, by definition, lower levels of inflammatory cytokines can be expected [6].”
BackgroundInfluentialSerotonergic regulation of energy metabolism in peripheral tissues
Choi, W., Moon, J. H., & Kim, H. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0546 · Cited by 43
“Chronic inflammation, especially in adipose tissue and liver, has been shown to promote insulin resistance (Hotamisligil 2017).”
BackgroundThe association between obesity and weight loss after bariatric surgery on the vaginal microbiota
Raglan, O., MacIntyre, D. A., Mitra, A., Lee, Y., Smith, A., Assi, N., Nautiyal, J., Purkayastha, S., Gunter, M. J., Gabra, H., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01011-2 · Cited by 45
“adipose tissue macrophages, cytokines and adipokines) can drive systemic inflammation [78, 79].”
BackgroundTang, H.-N., Liu, N., Feng, X.-J., Yang, Y.-Y., Fang, Y., Zhuang, S.-Q., Dai, Y., Liu, M.-L., & Tang, L.-L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02711-x · Cited by 30
“With the occurrence and development of obesity, inflammatory immune cells infiltrated into adipose tissue and other metabolically active organs, causing inflammation and insulin resistance [5, 6].”
BackgroundHost Metabolic Disorders Induced by Alterations in Intestinal Flora under Dietary Pesticide Exposure
Liu, J., Zhao, F., Wang, T., Xu, Y., Qiu, J., & Qian, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00273 · Cited by 39
Homeostatic and pathogenic roles of the GM3 ganglioside
Inokuchi, J., Kanoh, H., Inamori, K., Nagafuku, M., Nitta, T., & Fukase, K. (2021) · FEBS Journal · doi:10.1111/febs.16076 · Cited by 41
Hernández-García, E., Cueto, F. J., Cook, E. C. L., Redondo‐Urzainqui, A., Charro-Zanca, S., Robles‐Vera, I., Conde‐Garrosa, R., Nikolić, I., Sabio, G., Sancho, D., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00812-7 · Cited by 41
“Inflammation plays a clear role in metabolic dysfunction associated with obesity and IR [49, 50].”
BackgroundItoh, H., Ueda, M., Suzuki, M., & Kohmura‐Kobayashi, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839436 · Cited by 41
“This led to the establishment of the concept of ‘Metaflammation’ (8, 9).”
BackgroundInfluentialRetinoids in the Pathogenesis and Treatment of Liver Diseases
Melis, M., Tang, X., Trasino, S. E., & Gudas, L. J. (2022) · Nutrients · doi:10.3390/nu14071456 · Cited by 40
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Nature
- Published
- 2017-02-09
- Volume
- 542
- Issue
- 7640
- Pages
- 177-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2587680743
- Cited by
- 2,570
- References
- 144
- Citations by year
- 2026: 501 · 2025: 322 · 2024: 264 · 2023: 253 · 2022: 252 · 2021: 296 · 2020: 283 · 2019: 217 · 2018: 125 · 2017: 57
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL125753)
- National Institute of Allergy and Infectious Diseases (R01AI116901)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- inflammation, metabolic inflammation, immunometabolism, obesity, metabolic disorders, adipose tissue inflammation, non-communicable diseases, diabetes mellitus
- MeSH terms
- Animals, Clinical Trials as Topic, Hormones, Humans, Inflammation, Invertebrates, Metabolic Diseases, Obesity, Organelles, Signal Transduction, Cytokines, Evolution, Molecular, Genome-Wide Association Study, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.